首页> 中文期刊> 《中国老年学杂志》 >慢性肝病患者肝螺杆菌血清抗体水平分析

慢性肝病患者肝螺杆菌血清抗体水平分析

         

摘要

目的 分析不同病因慢性肝病患者血清肝螺杆菌抗体(抗H.hepaticus-IgG)相对抗体活性(RAA)以及螺杆菌抗原之间的交叉反应.方法 随机选取不同病因的慢性肝病患者(CLD) 76例(其中慢性乙型病毒性肝病27例、慢性丙型病毒性肝病25例、自身免疫性肝炎8例和慢性酒精性肝病16例)、健康献血者80名以及体检人群80名,应用ELISA方法检测吸收试验前后血清中抗H.hepaticus-IgG相对抗体活性.结果 CLD患者抗H.hepaticus-IgG抗体的RAA明显高于献血者和普通人群组(P <0.001);CLD患者和普通体检人群抗H.pylori-IgG抗体的RAA平均值明显高于献血者(P <0.001);CLD患者中除自身免疫性肝炎患者外,慢性乙型肝炎患者、慢性丙型肝炎及酒精性肝病患者抗H.hepaticus-IgG抗体的相对抗体活性反应均明显增高,慢性丙型肝炎患者抗H.hepaticus-IgG抗体的RAA值明显高于其他肝病患者(P<0.001),吸收试验前后抗H.hepaticus-IgG抗体的RAA值无显著性变化(P>0.05).结论 H.hepaticus和H.pylori的细胞表面蛋白具有较高的交叉反应,慢性肝病患者抗H.hepaticus-IgG抗体反应在吸收试验后仍保持较高水平.%Objective To analyze antibody relative activity surface proteins of anti-H. Hepaticus-IgG antibody in patients with chronic liver disease, and cross-reactivity between H. Hepaticus and H. Pylori antigens. Methods 76 patients with chronic liver disease (CLD) were randomly selected including chronic hepatitis B 27 cases, chronic hepatitis C 20 cases, autoimmune hepatitis5 cases, chronic alcoholic liver disease 16 cases, ELJSA was used, to test H. Hepaticus relative antibody activity before and after absorption test Results RAA of anti-H. Hepaticus-IgG antibody in CLD patients was significantly higher than that of average blood donor group and the general medical group (P <0. 001); RAA of anti- H. Pylori-IgG antibody in CLD patients and the general medical population was significantly higher than that of average RAA in blood donors (P < 0. 001); Except autoimmune hepatitis, RAA of anti-H. Hepaticus-IgG antibody in patients with chronic hepatitis B, chronic hepatitis C and alcoholic liver disease were significantly higher; RAA of anti-H. Hepaticus-IgG antibody in patients with chronic hepatitis C were significantly higher than other patients with liver disease (P < 0. 001). There was no significant difference between before and after absorption test RAA of anti-H. Hepaticus-IgG antibody (P > 0.05). Conclusions H. Hepaticus and H. Pylori cell surface proteins have high cross-reactivity, RAA of anti-H. Hepaticus-IgG antibody in patients with chronic liver disease remained higher lever after the absorption test.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号